In this talk, we discuss the paper “Chaos Meets Attention: Transformers for Large-Scale Dynamical Prediction” by Yi He et al., ICML Poster, 2025. Abstract: Generating long-term trajectories of dissipative chaotic systems autoregressively is a highly challenging task. The inherent positive Lyapunov exponents amplify prediction errors over time. Many chaotic systems possess a crucial property — …
Journal Club
Events
Calendar of Events
|
Sunday
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
In this talk, we discuss the paper “Insulin resistance prediction from wearables and routine blood biomarkers” by Ahmed A. Metwally et al., Nature, 2026. Abstract: Insulin resistance (IR), a primary precursor to type 2 diabetes, is characterized by impaired insulin action in tissues1. However, diagnostic methods remain expensive and inaccessible, which hinders early intervention2,3. … |
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
In this talk, we discuss the paper “Learning Longitudinal Health Representations from EHR and Wearable Data” by Yuanyun Zhang et al., arXiv, 2026. Abstract: Foundation models trained on electronic health records show strong performance on many clinical prediction tasks but are limited by sparse and irregular documentation. Wearable devices provide dense continuous physiological signals but … |
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
In this talk, we discuss the paper "A Metabolism-Informed Neural Network Identifies Pathways Influencing the Potency and Toxicity of Antimicrobial Combinations" by Harkirat Sigh Arora et al., npj drug discovery, 2026. Abstract: Antimicrobial resistance poses a major global threat, driven by diminishing efficacy of current treatments and limited new therapies. Combination therapy with existing drugs … |
0 events,
|

